RIGL - Rigel Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts6676
Avg. Estimate-0.14-0.14-0.4-0.36
Low Estimate-0.15-0.16-0.57-0.44
High Estimate-0.13-0.13-0.3-0.32
Year Ago EPS-0.16-0.14-0.44-0.4
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts6666
Avg. Estimate9.1M11.21M78.85M87M
Low Estimate7.87M9.96M63.2M52M
High Estimate9.77M12M87.13M110.01M
Year Ago Sales1.79MN/A44.51M78.85M
Sales Growth (year/est)409.20%N/A77.20%10.30%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-0.16-0.150.03-0.13
EPS Actual-0.16-0.140.03-0.11
Difference00.0100.02
Surprise %0.00%6.70%0.00%15.40%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.14-0.14-0.4-0.36
7 Days Ago-0.14-0.14-0.4-0.36
30 Days Ago-0.14-0.14-0.4-0.37
60 Days Ago-0.14-0.14-0.4-0.37
90 Days Ago-0.14-0.13-0.44-0.33
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days1122
Up Last 30 Days3122
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRIGLIndustrySectorS&P 500
Current Qtr.12.50%N/AN/A0.02
Next Qtr.N/AN/AN/A0.04
Current Year9.10%N/AN/A0.05
Next Year10.00%N/AN/A0.11
Next 5 Years (per annum)70.00%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A